March 29, 2022
Ad Scientiam, leader in digital biomarkers, continues its strong growth. A look back at the highlights of 2021 in figures.
Ad Scientiam, leader in digital biomarkers, continues its strong growth and 2021 was a particularly rich year for us.
A look back at the highlights of 2021 in figures.
